原发性肝癌患者介入治疗前后血清异常凝血酶原和甲胎蛋白变化的意义

郑海伦; 赵睿; 李大鹏; 汪强武; 汪建超; 王启之; 郑海伦; 赵睿; 李大鹏; 汪强武; 汪建超; 王启之

[1]

Yamamoto K, Imamura H, Matsuyama Y, et al.AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC[J].J Gastroenterol, 2010, 45(12):1272-1282.

[2]

王媛媛, 朱丽影, 钟丽华, 等.原发性肝癌患者TACE前后血清GP73动态变化[J/CD].中国肝脏病杂志:电子版, 2013, 5(2):14-18.

[3]

Nanashima A, Abo T, Taura N, et al.NX-PVKA levels before and after hepatectomy of hepatocellular carcinoma as predictors of patient survival:a preliminary evaluation of an improved assay for PIVKA-Ⅱ[J].Anticancer Res, 2013, 33(6):2689-2697.

[4]

Kobayashi M, Ikeda K, Kawamura Y, et al.High serum des-γ-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma[J].Cancer, 2009, 115(3):571-580.

[5]

Gao P, Li M, Tian QB, et al.Diagnostic performance of des-γ-carboxy prothrombin(DCP) for hepatocellular carcinoma:a bivariate meta-analysis[J].Neoplasma, 2012, 59(2):150-159.

[6]

Kaibori M, Ishizaki M, Matsui K, et al.Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma[J].J Surg Oncol, 2010, 102(5):462-468.

[7]

Matsubara M, Shiraha H, Kataoka J, et al.Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma[J].J Gastroenterol Hepatol, 2012, 27(10):1602-1608.

[8]

刘传苗, 徐静.肝细胞癌血清肿瘤标志物DCP、AFP-L3和AFP的表达及临床意义[J].蚌埠医学院学报, 2012, 37(9):1031-1033.

[9]

Nishikawa H, Osaki Y, Kita R, et al.Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma[J].Oncol Rep, 2014, 31(1):65-72.